Holen Sie sich die Stockscreener-App
2.04
3.32%
-0.07
Handel nachbörslich:
2.08
0.04
+1.96%
Schlusskurs vom Vortag:
$2.11
Offen:
$2.15
24-Stunden-Volumen:
102.37K
Relative Volume:
0.90
Marktkapitalisierung:
$38.09M
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
-22.73%
1M Leistung:
-49.13%
6M Leistung:
-56.41%
1J Leistung:
-57.75%
1-Tages-Spanne:
$1.8801
$2.30
1-Wochen-Bereich:
$1.8801
$2.6999
52-Wochen-Spanne:
$1.8801
$8.40
BioStem Technologies, Inc. Common Stock Stock (BSEM) Company Profile
Firmenname
BioStem Technologies, Inc. Common Stock
Sektor
Branche
Telefon
-
Adresse
-
Compare BSEM vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSEM
BioStem Technologies, Inc. Common Stock
|
2.04 | 38.09M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
BioStem Technologies, Inc. Common Stock Aktie (BSEM) Neueste Nachrichten
BioStem Technologies Completes $3 Million Private Placement Financing - The Globe and Mail
BioStem Technologies Completes $3 Million Private Stock and Warrants Offering - Kalkine Media
BioStem Technologies Secures $3 Million Private Placement; Issues Stock at $4.08 and Warrants - TradingView
BioStem Technologies raises $3M in private placement By Investing.com - Investing.com South Africa
BioStem Technologies raises $3M in private placement - Investing.com
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewswire
BioStem (BSEM) lines up $40M in potential stock sales—how much has it tapped? - Stock Titan
BioStem Technologies Establishes $40 Million Committed Equity Facility With Roth Principal Investments - TradingView
New stock sale deal could fund BioStem (NASDAQ: BSEM) for up to three years - Stock Titan
BioStem Technologies Secures Access to $40 Million Equity Facility - citybiz
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility - GlobeNewswire
BioStem (NASDAQ: BSEM) lines up $40M stock deal that could dilute investors - Stock Titan
Up to $40 million in shares could be sold by BioStem. It does not have to use the facility. - Stock Titan
BioStem Technologies (BSEM) CAO increases direct holdings with RSU share conversion - Stock Titan
BioStem Technologies (BSEM) director now holds 33,928 shares after RSU exercise - Stock Titan
BioStem Technologies (BSEM) CEO receives 25K shares via RSUs - Stock Titan
BioStem Technologies (BSEM) CFO lifts direct stake to 58,062 shares - Stock Titan
BioStem Technologies (BSEM) insider adds 17,196 shares at $0 - Stock Titan
BioStem Technologies (BSEM) CCO adds 500 shares through equity award - Stock Titan
BioStem Technologies (BSEM) director gains 7,671 shares - Stock Titan
BioStem Technologies Reports Second Quarter 2026 Financial Results - GlobeNewswire
BioStem Technologies wins Nasdaq approval, begins trading August 7 - Dealroom
BioStem Technologies (Nasdaq:BSEM)Stock Analysis - Simply Wall Street
BioStem Technologies, Inc. (BSEM) Company Information - Simply Wall Street
BioStem Technologies Uplists to Nasdaq Capital Market - The Globe and Mail
symbol__ Stock Quote Price and Forecast - CNN
BioStem Technologies Uplists to Nasdaq Capital Market - TipRanks
BioStem Technologies Announces Nasdaq Uplisting - GlobeNewswire
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission - Yahoo Finance
Finanzdaten der BioStem Technologies, Inc. Common Stock-Aktie (BSEM)
Es liegen keine Finanzdaten für BioStem Technologies, Inc. Common Stock (BSEM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
BioStem Technologies, Inc. Common Stock-Aktie (BSEM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Matuszewski Jason | Chief Executive Officer |
Oct 07 '26 |
Option Exercise |
2.00 |
250,000 |
500,000 |
1,553,551 |
| SMITH-VAN VURST ANDREW | Chief Operating Officer |
Sep 17 '26 |
Option Exercise |
0.00 |
9,574 |
0 |
1,539,809 |
| Matuszewski Jason | Chief Executive Officer |
Sep 17 '26 |
Option Exercise |
0.00 |
16,650 |
0 |
1,303,552 |
| SMITH-VAN VURST ANDREW | Chief Operating Officer |
Sep 15 '26 |
Option Exercise |
0.00 |
7,622 |
0 |
1,530,235 |
| POE BRANDON | Chief Financial Officer |
Sep 15 '26 |
Option Exercise |
0.00 |
1,694 |
0 |
58,062 |
| Matuszewski Jason | Chief Executive Officer |
Sep 15 '26 |
Option Exercise |
0.00 |
8,469 |
0 |
1,286,902 |
| WARRINGTON KENNETH HOWARD JR | Director |
Sep 15 '26 |
Option Exercise |
0.00 |
1,694 |
0 |
33,928 |
| FORTUNATO MICHAEL A | Chief Accounting Officer |
Sep 15 '26 |
Option Exercise |
0.00 |
4,234 |
0 |
68,664 |
| HASSETT BARRY | Chief Commercial Officer |
Sep 09 '26 |
Option Exercise |
0.00 |
500 |
0 |
5,003 |
| UNGRODT JODI | Director |
Aug 27 '26 |
Option Exercise |
0.00 |
5,647 |
0 |
11,295 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):